MedPath
NMPA Approval

Rifampicin for Injection

国药准字H20249368

November 15, 2024

Drug Information

注射用利福平

注射剂

0.6g

化学药品

November 15, 2024

Company Information

Applicant Company

中山市火炬开发区健康路17号A栋二层

Manufacturing Company

中山火炬开发区国家健康基地内健康路17号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用利福平 - NMPA 批准文号 | MedPath